Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.
about
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.Translating evidence into policy for cardiovascular disease control in IndiaSMARTHealth India: Development and Field Evaluation of a Mobile Clinical Decision Support System for Cardiovascular Diseases in Rural India.Reduced heart function predicts drug-taking compliance and two-year prognosis in chinese patients with stable premature coronary artery disease.Age and Gender Disparities in Evidence-based Treatment for Coronary Artery Disease in the Community: A Cross-sectional StudyThe scope of cell phones in diabetes management in developing country health care settings.Influence of education and working background on physicians' knowledge of secondary prevention guidelines for coronary heart disease: results from a survey in China.Gender differences in 7 years trends in cholesterol lipoproteins and lipids in India: Insights from a hospital databaseEvaluation of statin prescriptions in type 2 diabetes: India Heart Watch-2Optimal in-hospital and discharge medical therapy in acute coronary syndromes in Kerala: results from the Kerala acute coronary syndrome registry.Epidemiology of cardioprotective pharmacological agent use in stable coronary heart disease.Impact of the CD40-CD40L dyad in Alzheimer's diseasePrevalence and control of cardiovascular risk factors in stable coronary artery outpatients in India compared with the rest of the world: An analysis from international CLARIFY registry.Non-physician health workers for improving adherence to medications and healthy lifestyle following acute coronary syndrome: 24-month follow-up study.Recent trends in epidemiology of dyslipidemias in India.Translating intentions to prescriptions: Mind the gap!
P2860
Q33925329-69CDAA7F-A638-49D0-B630-D9B13AE0790FQ34611280-12B8CDEB-5168-4AAD-8EDC-4B8F36FAA8B3Q34766584-0698D481-90CB-47EF-95E6-E17002D0ACA1Q34840050-292499F2-79D7-4050-ADDD-6755AB2DC7EEQ35234413-CFB065D3-D321-4CB4-A32F-70A7610654BEQ35337792-35636E79-A3A2-44DD-8660-3064F2BB3050Q35810154-FCDE4A6F-9144-4CE7-8C6F-8D119C68BF2CQ36687507-B565C225-BCB6-4D52-9614-EB608DE62D96Q37236445-206DB5D6-56ED-4A96-98FE-53E1111E818CQ37315233-64F99A5F-9527-44C5-9B15-675E5E374BDFQ37388202-12F2AEB3-D38C-4023-8AD8-9CCF8DAE556CQ37703298-3BD1A09A-17D0-4536-8C55-C6836BBF2D8AQ38617666-08428C80-4E6C-4144-9AC6-F105B01EF327Q39119008-0CBBD9BF-D9B9-4AD7-81B4-B98158524A3CQ39397049-7A8C9E3C-93E9-458A-BEF0-F94BC9BC5141Q40380728-13954FF2-694E-43F0-9D39-9C316FD016A5
P2860
Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Low use of statins and other c ...... y and secondary care in India.
@en
Low use of statins and other c ...... y and secondary care in India.
@nl
type
label
Low use of statins and other c ...... y and secondary care in India.
@en
Low use of statins and other c ...... y and secondary care in India.
@nl
prefLabel
Low use of statins and other c ...... y and secondary care in India.
@en
Low use of statins and other c ...... y and secondary care in India.
@nl
P2093
P2860
P356
P1476
Low use of statins and other c ...... ry and secondary care in India
@en
P2093
Aachu Agrawal
Ajeet Bana
Atul Kasliwal
Krishna K Sharma
Prakash C Deedwania
Rajeev Gupta
Ravindra K Tongia
Sanjeeb Roy
P2860
P304
P356
10.2147/VHRM.S8017
P407
P577
2009-11-23T00:00:00Z